Manchester, UK, 27 February 2023 — COUCH Health today announced the publication of a new report “The Power of Patient Engagement in MedTech”.
The report was conducted and produced by the COUCH Health in-house research team, who spoke to organisations with expertise in medical device development, clinical research, and patient engagement to learn more about opportunities for patient engagement in MedTech.
The report draws on the insights and data gained from recent literature, as well as the real-life experiences shared from these organisations, to provide an understanding of the current landscape of patient engagement in MedTech and the key opportunities for the industry moving forward.
Commenting on the report, Natasha Ratcliffe, Director of Community Engagement and Partnerships at COUCH Health, remarks:
“At COUCH Health, we advocate for engaging with and involving patients as early as possible with our clients, particularly in the development and testing of potential new treatments and products. We know from experience that embedding patient engagement isn’t easy, and our research has revealed a number of recurring challenges across the MedTech industry that are currently hindering uptake of patient engagement. That is why I welcome this report and the impact it may have”
Key report learnings
+ Patient engagement in MedTech is necessary and a logical investment. It would be remiss of the organisations developing medical devices, that are going to be used by patients, to not involve those very patients in the design and development process.
+ The benefits of patient engagement are two-fold. Engaging with patients throughout the device development processes brings benefits to both patients and the industry in many ways.
+ There are barriers, but they can be overcome. We know from experience that embedding patient engagement isn’t easy. However, real-world examples demonstrate they can be overcome, and patient engagement can have a positive — even life-changing — impact.
+ There is no better time to start than now. More people are getting on board, and regulators are starting to catch up. Patient engagement is something that the MedTech sector can’t afford to avoid.
Click here to access the report in full: https://couchhealth.agency/the-power-of-patient-engagement-in-medtech/
COUCH Health is a global creative health engagement agency that has purpose at its heart. That purpose is driven by a very personal experience.
In 2002, one of our founders lost their father to prostate cancer:
- Had his doctor been sufficiently educated on the signs to look for, he might still be here today.
- Had their father understood his own symptoms, he might still be here today.
- Had their father’s healthcare team been aware of potential life-saving clinical trials, he might still be here today.
We know that others will have similar experiences, and these experiences will continue to happen until lasting change is made. So, our purpose is to create lasting change. To achieve this, our team has one main mission: to make health human.
That means we’re challenging the norm to make health experiences more inclusive, equitable, accessible and empathetic. And we can only make this happen if we understand the real-life challenges that are at play.
By connecting with people — the patients, caregivers, communities, healthcare professionals and life science companies — we’re ensuring that we’re making changes that matter to truly improve health experiences for all.
Our best-in-class, human-centric approach means that everything we do at COUCH Health, from insight research to engagement activities, through to content creation and marketing approaches, is always conducted with our mission in mind — making health human.
What we do:
- Human insights
- Community engagement
- Creative services for patients and communities
- Healthcare advertising for life science companies
Everything is underpinned by the desire to make health more equitable and thus more human, and this is #theCOUCHway. Are you ready to start your next project?
Let's talk. e. [email protected] | t. +44 (0) 161 300 0874